.jpg)
Axsome touts success of phase 3 trial of Sunosi in ADHD, adding to 'string of recent wins'
Fast-rising New York City central nervous system specialist Axsome has scored in a phase 3 trial testing Sunosi on adults with attention deficit hyperactivity disorder (ADHD).
Fast-rising New York City central nervous system specialist Axsome has scored in a phase 3 trial testing Sunosi on adults with attention deficit hyperactivity disorder (ADHD).
